These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Postmarketing experience with auranofin in the Federal Republic of Germany. Schattenkirchner M; Missler B; Mulz D Scand J Rheumatol Suppl; 1986; 63():57-66. PubMed ID: 3299683 [TBL] [Abstract][Full Text] [Related]
3. Auranofin: first choice for remission-inducing drug (RID) therapy in rheumatoid arthritis? Bandilla K; Missler B; Klein-Reesink B Scand J Rheumatol Suppl; 1986; 63():47-54. PubMed ID: 3474777 [TBL] [Abstract][Full Text] [Related]
4. The moderate intestinal side effects of auranofin do not require prophylactic therapy with a bulkforming agent. Dutch Ridaura Study Group. van Beusekom HJ; van de Laar MA; Franssen MJ; van Valburg JA; Gijzel WP; Couvée JE Clin Rheumatol; 1997 Sep; 16(5):471-6. PubMed ID: 9348142 [TBL] [Abstract][Full Text] [Related]
5. Auranofin versus penicillamine in rheumatoid arthritis. One-year results from a prospective clinical investigation. Manthorpe R; Hørbov S; Sylvest J; Vinterberg H Scand J Rheumatol; 1986; 15(1):13-22. PubMed ID: 3083505 [TBL] [Abstract][Full Text] [Related]
6. Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study. Rao UR; Naidu MU; Kumar TR; Shobha U; Askar MA; Ahmed N; Sarada P; Venubabu K; Shantaram V; Menon GN J Rheumatol; 1995 Jul; 22(7):1235-40. PubMed ID: 7562751 [TBL] [Abstract][Full Text] [Related]
7. [Clinical effectiveness and tolerance of auranofin in patients with chronic polyarthritis. Results of a multicenter long-term study]. Klein G; Schwann H; Mirtl B; Thumb N; Mayerhofer F; Singer F; Tausch G; Gaismayer K; Rieder H; Hartweger A Z Rheumatol; 1988; 47(5):342-6. PubMed ID: 3149087 [TBL] [Abstract][Full Text] [Related]
8. Incidence and management of diarrhea during longterm auranofin therapy. Wallin BA; McCafferty JP; Fox MJ; Cooper DR; Goldschmidt MS J Rheumatol; 1988 Dec; 15(12):1755-8. PubMed ID: 3265956 [TBL] [Abstract][Full Text] [Related]
9. Auranofin in rheumatoid arthritis: use in patients with side-effects or lack of effect to gold sodium thiomalate or gold thioglucose and/or D-penicillamine. A prospective one year investigation. Manthorpe R; Tvede N; Bendixen G Scand J Rheumatol; 1988; 17(5):401-5. PubMed ID: 3145556 [No Abstract] [Full Text] [Related]
10. Auranofin and gold sodium thiomalate in the treatment of rheumatoid arthritis: a one-year, double-blind, comparative multicenter study. Schattenkirchner M; Bröll H; Kaik B; Müller-Fassbender H; Rau R; Zeidler H Klin Wochenschr; 1988 Feb; 66(4):167-74. PubMed ID: 3131571 [TBL] [Abstract][Full Text] [Related]
11. Comparison between sodium aurothiomalate and auranofin in rheumatoid arthritis. Results of a two-year open randomized study. Harth M; Davis P; Thompson JM; Menard H; Beaudet F Scand J Rheumatol; 1987; 16(3):177-84. PubMed ID: 3110944 [TBL] [Abstract][Full Text] [Related]
12. Auranofin and D-penicillamine: a one year comparative study of safety and efficacy in patients with rheumatoid arthritis followed by a two year open assessment of auranofin. Franchimont P; Hauwaert C; Vanschoubroek K Clin Rheumatol; 1984 Mar; 3 Suppl 1():75-82. PubMed ID: 6432417 [TBL] [Abstract][Full Text] [Related]
13. Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis. Champion GD; Cairns DR; Bieri D; Adena MA; Browne CD; Cohen ML; Day RO; Edmonds JP; Graham GG; de Jager J J Rheumatol; 1988 Jan; 15(1):28-34. PubMed ID: 3280795 [TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy and safety of auranofin: a review of clinical experience. Blodgett RC; Pietrusko RG Scand J Rheumatol Suppl; 1986; 63():67-78. PubMed ID: 3110943 [TBL] [Abstract][Full Text] [Related]
16. Auranofin (SK&F) in early rheumatoid arthritis: results from a 24-month double-blind, placebo-controlled study. Effect on clinical and biochemical assessments. Johnsen V; Borg G; Trang LE; Berg E; Brodin U Scand J Rheumatol; 1989; 18(5):251-60. PubMed ID: 2688083 [TBL] [Abstract][Full Text] [Related]
17. Gold colitis induced by auranofin treatment of rheumatoid arthritis: case report and review of the literature. Langer HE; Hartmann G; Heinemann G; Richter K Ann Rheum Dis; 1987 Oct; 46(10):787-92. PubMed ID: 3318725 [TBL] [Abstract][Full Text] [Related]
18. [Well controlled comparative study in early rheumatoid arthritis with gold sodium thiomalate vs. auranofin]. Yamamoto S; Mitomo N; Saito T; Nishioka K; Inoue K; Uchida S; Ohata N; Murasawa A; Suzuki A; Mitsui T Ryumachi; 1990 Feb; 30(1):26-44. PubMed ID: 2116042 [TBL] [Abstract][Full Text] [Related]
19. A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis. Jessop JD; O'Sullivan MM; Lewis PA; Williams LA; Camilleri JP; Plant MJ; Coles EC Br J Rheumatol; 1998 Sep; 37(9):992-1002. PubMed ID: 9783766 [TBL] [Abstract][Full Text] [Related]
20. A three year comparative multicenter study of auranofin (AF) and gold sodium thiomalate (GST) in the treatment of rheumatoid arthritis (RA). Rau R; Schattenkirchner M; Müller-Fassbender H; Kaik B; Zeidler H Clin Rheumatol; 1987 Sep; 6 Suppl 2():43-52. PubMed ID: 3121238 [No Abstract] [Full Text] [Related] [Next] [New Search]